BlackRock Japan’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$36.7M Buy
299,847
+10,937
+4% +$1.34M 0.12% 200
2016
Q3
$35.4M Buy
288,910
+3,042
+1% +$392K 0.12% 196
2016
Q2
$33.4M Buy
285,868
+2,673
+0.9% +$379K 0.12% 201
2016
Q1
$39.4M Sell
283,195
-43,106
-13% -$6.33M 0.15% 158
2015
Q4
$62.2M Buy
326,301
+18,994
+6% +$3.32M 0.23% 94
2015
Q3
$48.1M Sell
307,307
-5,831
-2% -$1.06M 0.19% 123
2015
Q2
$56.6M Buy
313,138
+74,641
+31% +$12.9M 0.22% 106
2015
Q1
$41.3M Sell
238,497
-13,727
-5% -$2.48M 0.17% 147
2014
Q4
$46.7M Buy
252,224
+21,000
+9% +$3.89M 0.18% 136
2014
Q3
$38.3M Buy
231,224
+14,595
+7% +$2.4M 0.17% 144
2014
Q2
$33.8M Sell
216,629
-21,650
-9% -$3.42M 0.15% 157
2014
Q1
$36.2M Buy
238,279
+14,450
+6% +$2.3M 0.16% 151
2013
Q4
$29.7M Sell
223,829
-16,781
-7% -$2.01M 0.13% 178
2013
Q3
$27.9M Buy
240,610
+10,144
+4% +$1.11M 0.13% 181
2013
Q2
$21.3M Buy
+230,466
New +$22.2M 0.1% 240

Other funds holding ALXN